Does ABIRATERONE\ABIRATERONE Cause Malignant neoplasm progression? 5 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with ABIRATERONE\ABIRATERONE. This represents 4.8% of all adverse event reports for ABIRATERONE\ABIRATERONE.
5
Reports of Malignant neoplasm progression with ABIRATERONE\ABIRATERONE
4.8%
of all ABIRATERONE\ABIRATERONE reports
3
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ABIRATERONE\ABIRATERONE?
Of the 5 reports, 3 (60.0%) resulted in death, 2 (40.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE\ABIRATERONE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE\ABIRATERONE Cause?
Drug ineffective (21)
Fatigue (12)
Hot flush (10)
Death (9)
Disease progression (7)
Atrioventricular block complete (6)
Long qt syndrome (6)
Prostatic specific antigen increased (6)
Syncope (6)
Anaemia (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ABIRATERONE\ABIRATERONE Alternatives Have Lower Malignant neoplasm progression Risk?
ABIRATERONE\ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE\ABIRATERONE vs ABRAXANE
ABIRATERONE\ABIRATERONE vs ABROCITINIB
ABIRATERONE\ABIRATERONE vs ACALABRUTINIB
ABIRATERONE\ABIRATERONE vs ACAMPROSATE